Chapter 28 - HAYES BIOMEDICAL WITHOUT A HAYESThe court suspended the forced-sale covenant for ninety days.
Richard’s attorneys called the order unlawful interference with private property.
The independent receiver replied that the shares had been preserved through fraud, stolen trusts, and criminal guardianships. Ordinary contract enforcement could not proceed as though those facts did not exist.
Eleanor did not ask to run the company.
Vivian did not ask for it back.
Gabriel had no interest in replacing Richard.
April was ten.
The company’s future could not become a family reunion.
Employees testified first.
Many had joined years after the illegal trials ended. They manufactured legitimate treatments, maintained laboratories, and supported families on ordinary wages.
A production supervisor named Rosa Delgado told the court:
“Do not use our jobs as the reason a Hayes must remain in control. Also do not destroy our jobs to prove the Hayes family is gone.”
Patients testified next.
April’s clotting treatment had been converted into a safe protocol, but several rare-drug programs still depended on company laboratories.
Immediate closure would create shortages.
Victims testified last.
They did not want the company preserved so completely that its value outranked restitution.
The receiver proposed division.
The unlawful neurological program would close permanently.
Its records and patents would enter public research custody.
The general medical business would become a public-benefit corporation.
Employees would elect board representatives.
Patients and medical ethicists would hold oversight seats.
Victim restitution would receive a defined share of profits and sale proceeds.
April’s visible trust would preserve its financial value without granting her childhood voting authority.
The hidden Children’s Ledger assets would be separated from corporate management.
At eighteen, April could keep her economic interest, sell it, or contribute shares to the public-benefit structure.
She would not inherit a chief executive title.
Vivian supported the plan.
Richard opposed it from prison.
The legacy directors attempted to move patents before the vote. Forensic controls caught the transfer. Two resigned. One faced criminal charges.
The restructuring passed.
No Hayes descendant held a permanent board seat.
The company retained the name temporarily because changing medication labels immediately could create safety problems. After a two-year transition, employees voted to rename it Meridian Health Sciences.
Vivian disliked the name.
She did not possess a veto.
The affordable clotting treatment was licensed to multiple manufacturers. April’s health no longer depended on one company.
The hidden trust contained one hundred eighty-six million dollars, but not all belonged to the children.
Forty-one million came from property stolen through custody cases.
Twenty-eight million represented legitimate investment growth.
The rest included corporate evidence funds, legal reserves, and assets with uncertain ownership.
The court refused to announce a single amount as April’s inheritance.
Ownership would be determined claim by claim.
During the audit, accountants found a separate entity.
Sunflower House.
Marianne had controlled it through her false identity, Mary Harlow.
The account held twenty-three million dollars and six properties used to shelter missing mothers.
Some money came from Richard’s private accounts.
Other deposits came from companies belonging to women Marianne claimed she was protecting.
No court had authorized the transfers.
Eleanor confronted her mother.
“Did you take their money?”
“I moved it before their husbands could.”
“Did you return it?”
“Sometimes.”
“Who decided?”
Marianne looked toward the floor.
May you like
“I did.”
👉 Hayes Biomedical had been separated from the family, but Marianne’s secret refuge revealed that resistance had become another place where one woman controlled other survivors’ property.
